Day: March 29, 2022

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — Reservoir Media, Inc. (NASDAQ: RSVR) (“Reservoir” or the “Company”), an award-winning independent music company, today announced a new deal for the catalog of the late lyricist Larry Kusik, best known for his collaborations on theme songs from blockbuster films like The Godfather and Romeo and Juliet. Kusik was a prolific lyricist whose works can be heard in some of the most iconic films released during the 1960s and 1970s. He notably penned the lyrics for “Speak Softly Love,” the lyricized theme from 3x-Academy Award-winning film The Godfather, which celebrated its 50th anniversary this month and is widely recognized as one of the greatest films of all time. “Speak Softly Love” won Kusik an ASCAP award and was recorded by several artists, with Andy Williams’ version climbing to #34 on...

IRVINE, Calif. and MIAMI, March 29, 2022 (GLOBE NEWSWIRE) — CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the company’s TRANBERG® Thermal Therapy System will be used by Focalyx Technologies, developer of image-guided fusion target devices, to conduct a 20-patient, Phase I clinical study titled, “Targeted MRI/US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.” The study will utilize the Focalyx® Fusion medical device for treatment planning, image fusion, real-time image guidance during treatment, and CLS’s TRANBERG® Thermal Therapy System for high-precision, focal laser ablation. Other instruments will be used during the procedure as well. The study will be conducted by Urological Research Network, LLC, a Florida-based, not-for-profit clinical research organization. “CLS...

Dosed first patient in VIP152 and pembrolizumab combination arm of study VNC-152-101 Preliminary findings in gynecologic malignancies will be presented as a poster at upcoming AACR Annual Meeting in April 2022 Anticipate initiating Phase 2 studies of VIP152 in 2H2022 IND filing for small molecule drug conjugate (SMDC) candidate, VIP236, in solid tumors on-target for 2H2022 Approved for German government research allowance of up to EUR 6 million Expected cash runway through 2023 PALO ALTO, Calif., March 29, 2022 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported financial results for the fourth quarter and full year ended December 31, 2021, and provided a corporate update. “We...

Study results demonstrate lead compounds increase GCase protein levels, activity and co-localization in the lysosome, and decrease toxic substrate accumulation BETHESDA, Md., March 29, 2022 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company transforming the drug discovery paradigm with structurally targeted allosteric regulators identified with its proprietary computational discovery platform, today presented new pre-clinical data from its Gaucher Disease (GD) program. The results were highlighted in a poster presentation at the 2022 Glycolipid and Sphingolipid Biology GRC being held March 27 – April 1, 2022, in Castelvecchio Pascoli, Italy. The data show that the tested compounds increase the levels and activity of the beta-glucocerebrosidase (GCase) protein, increase co-localization of...

The Continuation Application Seeks to Cover Wireless Motion Detection and Imaging, Governed by AI SAN DIEGO, March 29, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. ( OTC PINK: GTCH ) (“GBT” or the “Company”), filed a continuation application (#17694384) for its wireless motion detection and imaging patent, which has been assigned an internal code name “Apollo”. The non-provisional patent application seeks to protects a radio based, real time motion detection methods and systems. The Company has recently received a notice of allowance with respect to the application. The continuation application aims to broaden the technology’s protection and scope. The patent includes GBT’s AI technology that controls radio waves transmissions/reflections, analyzing the data to construct 2D/3D images of stationary and in-motion objects. The Company...